Laura Andronicos
Laura Andronicos reports on evidence-heavy clinical research and policy shifts across medicine, with a focus on how new data changes practice at the coalface. She writes for The Medical Republic and its specialist sister titles, tracking the movement from trial findings and systematic reviews into day-to-day decisions in primary care, oncology, rheumatology and gastroenterology.
Clinical evidence and practice change
Much of her work at The Medical Republic centres on new studies that challenge or refine established protocols, including coverage of prostate-specific antigen screening debates, colonoscopy effectiveness and implantable immunotherapy approaches in cancer. Her reporting on topics such as late-onset anxiety and Parkinson’s risk, RSV vaccination in younger adults, and osteoporosis guidelines highlights how emerging evidence can alter risk stratification, screening recommendations and treatment thresholds. She consistently grounds stories in trial design, endpoints and quantified outcomes, rather than broad claims, helping clinicians understand the strength and limits of the evidence behind proposed changes.
Oncology and cancer prevention
Through Oncology Republic she follows cancer care from prevention to advanced treatment, focusing on how research translates into survival and quality-of-life metrics. Her pieces examine links between obesity and cancer, the predictive value of “face age” for cancer survival, next-generation combination therapies for bladder cancer, and new drug subsidies and registrations that reshape access to treatment. She also covers whole-genome sequencing in oncology, giving attention to how genomics and risk profiling influence screening and personalised therapy decisions. Across these stories she tracks both scientific detail and system-level implications, such as reimbursement and guideline change, rather than treating oncology as a purely research or purely policy beat.
Musculoskeletal and rheumatology research
In Rheumatology Republic her work focuses on musculoskeletal disease and pain management, with particular emphasis on large, long-duration studies. She reports on krill oil trials in knee osteoarthritis, detailing changes in pain scores, stiffness and function, and clearly separating clinically meaningful effects from modest statistical improvements. Her coverage of low-cost interventions and adjunctive therapies reflects an interest in options that can realistically be integrated into everyday practice, not just experimental approaches. Across rheumatology stories she returns to measurable patient outcomes and safety profiles, giving equal weight to benefits, limitations and unanswered questions.
Gut, metabolic and lifestyle-related health
Writing for The Gut Republic, she covers the intersection of digestive health, sleep, metabolic markers and psychopharmacology. Her articles include work on how good-quality sleep reduces digestive symptoms, comparative weight gain profiles across antidepressants, and biomarkers identified for type 2 diabetes. These pieces link lifestyle factors, mental health treatment and metabolic risk, showing how small clinical decisions around medication choice or sleep management can accumulate into significant long-term outcomes. She treats gut and metabolic topics as part of a broader system, connecting them to cardiometabolic and cancer risk rather than isolating them as niche conditions.
Infectious disease, respiratory and protective equipment
She regularly covers infectious disease and respiratory health, including RSV vaccination impacts on infant hospitalisation and the extension of RSV vaccine availability to adults under 60. Her reporting on mask technology and modifications, such as a rubber-band adaptation that allows surgical masks to achieve N95-equivalent protection, focuses on practical, low-cost tools clinicians and health systems can deploy quickly. These articles combine virology, vaccine effectiveness and occupational safety with close attention to how front-line staff can adjust protocols in response to new evidence.
Breadth across cardiovascular, reproductive and AI in healthcare
Beyond her core strands, she writes on cardiovascular research, reproductive health and technology in medicine. At The Medical Republic and Oncology Republic she has covered highlights from major cardiology scientific sessions, contraceptive formulation and cancer risk, and the addition of new contraceptive options to public subsidy schedules. She also reports on artificial intelligence in healthcare, offering comprehensive guides to how AI tools are being evaluated and adopted in clinical settings. Across this broader portfolio she maintains a consistent approach: translating technical findings, regulatory decisions and technology developments into clear, outcome-focused narratives that clinicians can act on.
4 more health journalists.
Abida Tasnim
Abida Tasnim is a health writer for The Daily Star who focuses on clear, practical guidance that helps readers recognise risks early and act before everyday illnesses turn into wider public health problems. She reports on infectious disease prevention, using measles coverage to show how outbreaks start with individual decisions and behaviours, not just hospital statistics. Her work explains what happens during an outbreak and then anchors the story in simple steps people can take, such as avoiding crowded places when symptoms appear, practising good hygiene, and seeking medical advice early. She writes direct, action‑oriented health explainers that turn clinical questions about contagion and disease burden into everyday choices. Across her beat, she stresses early recognition, timely care, and prevention as the foundations of healthier communities.
Adrián Carballo Casla
Adrián Carballo Casla stands out for turning complex cohort data on ageing into clear, food‑level advice on what older adults should eat to protect brain health and slow chronic disease. He is a researcher in nutritional epidemiology focused on ageing and chronic disease prevention and a postdoctoral researcher in geriatric epidemiology at Karolinska Institutet, writing health explainers for The Conversation. He reports on how diet quality, especially Mediterranean and Mind‑style patterns, shapes dementia risk, grey matter loss and neurocognitive ageing, and how healthy versus pro‑inflammatory diets alter multimorbidity trajectories. His articles translate findings on flavonoids, polyphenols, folate, omega‑3 fats and dietary nitrates into specific food choices and small, practical changes. Much of his coverage is anchored in his own studies on multimorbidity, high‑risk older adults and tailored dietary recommendations, often syndicated to other outlets.
Ahmed Elbediwy
Ahmed Elbediwy brings a lab-based understanding of cancer biology and clinical biochemistry to public-facing health reporting, linking drug mechanisms and molecular pathways to everyday choices about medicines and products. He writes for The Conversation on weight-loss injections, cancer overdiagnosis and anti-ageing supplements, focusing on obesity medicine, cancer signalling, screening trade-offs, skincare and supplement science. His pieces on GLP-1 drugs such as Ozempic, Wegovy and Mounjaro explain why some people do not respond, how gut hormones and appetite signals work, and where psychological support and nutrition fit alongside prescriptions. He co-authors explainers on cancer risk and overdiagnosis and on whether supplements can reverse ageing, separating established knowledge from emerging research. An award-winning senior lecturer at Kingston University, he favours clear, structured explainers, careful definition of key terms and evidence-based appraisal over hype.
Amanda Sheppeard
Amanda Sheppeard is a managing editor and health journalist known for long, detailed explainers that connect complex clinical research, disability policy and political narratives with the daily realities of doctors and patients. She works at The Medical Republic across editorial leadership and commercial content while reporting widely on medicine for its specialist titles. Her real beat spans autism, disability policy, autoimmune disease, infectious threats and system pressures in primary care and hospitals. She covers subjects such as autism diagnosis and the NDIS, rheumatology’s clinical shifts, weight-loss agents in rheumatoid arthritis, infection control, antimicrobial resistance and new modalities like CAR T-cell therapy and microneedles. She reports by doing the synthesis inside the story, linking trial design, molecular targets, funding rules and policy changes to concrete decisions and workflows in clinics and hospitals.